Oragenics Inc Sustainability Reports
Oragenics, Inc. is a development-stage biotechnology company focused on the research and development of novel therapies for neurological conditions and infectious diseases. The company specializes in delivering brain-targeted therapeutics utilizing its proprietary intranasal delivery technology platform.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 549300639MGD19K4ZW90
1 reports from 2018 to 2018
Company Profile
Oragenics, Inc. is a development-stage biotechnology company focused on the research and development of novel therapies for neurological conditions and infectious diseases. The company specializes in delivering brain-targeted therapeutics utilizing its proprietary intranasal delivery technology platform.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
